Ascendis Pharma AS Cash Flow Reinvestment Rate

Latest as of December 2025: 0.05x

Ascendis Pharma AS cash flow reinvestment rate. Ascendis Pharma AS (A71) has a Cash Flow Reinvestment Rate of 0.05x as of December 2025, reinvesting €3.39 Million (capex €3.39 Million ) from operating cash flow of €73.40 Million. Explore Ascendis Pharma AS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.05x
(Capex + Investments) / Operating CF

Total Reinvested

€3.39 Million
Capex + Investments

Operating Cash Flow

€73.40 Million
EUR

Capital Expenditures

€3.39 Million
EUR

Cash Flow Reinvestment Rate of Ascendis Pharma AS (2025–2025)

Cash flow reinvestment rate of Ascendis Pharma AS from 2025 to 2025. Historical reinvestment intensity for Ascendis Pharma AS across 1 annual periods. Explore Ascendis Pharma AS capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Ascendis Pharma AS Cash Flow Reinvestment Rate by Year (2025–2025)

Ascendis Pharma AS cash flow reinvestment rate by year from 2025 to 2025. Year-by-year capital reinvestment analysis for Ascendis Pharma AS. For the full cash flow conversion analysis, see cash efficiency ratio of Ascendis Pharma AS.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 0.16x €8.48 Million €53.90 Million €8.48 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow